Koers Atrinsic, Inc. Other OTC
Aandelen
US04964C2089
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 4,39 mln. 4,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,79 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,65 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 7,63 mln. 7,09 mln. | Nettoliquiditeiten 2023 | 4,06 mln. 3,77 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,94
x | K/w-verhouding 2023 |
-0,86
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 78,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01-02-16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01-02-16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03-02-94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28-07-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers PTIX
- Koers